EDGAR Filing Documents for 0001140361-17-038695

Form 8-K - Current report:

SEC Accession No. 0001140361-17-038695

Filing Date

2017-10-16

Accepted

2017-10-16 08:55:28

Documents

Period of Report

2017-10-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	25140
2	EXHIBIT 5.1	ex5_1.htm	EX-5.1	11840
3	EXHIBIT 10.1	ex10_1.htm	EX-10.1	183217
4	EXHIBIT 10.2	ex10_2.htm	EX-10.2	33169
5	EXHIBIT 99.1	ex99_1.htm	EX-99.1	8450
6		image0.jpg	GRAPHIC	100639
7		image1.jpg	GRAPHIC	6923
8		image00002.jpg	GRAPHIC	94256
9		image00003.jpg	GRAPHIC	79423
	Complete submission text file	0001140361-17-038695.txt		650633

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555

Business Address 6300 DUMBARTON CIRCLE FREMONT CA 94555 510-456-3805

Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)